How much does the third-generation targeted drug Osimertinib cost?

Osimertinib (Osimertinib) is a kinase inhibitor used to treat cancer called non-small cell cancer (NSCLC) when the cancer is in its advanced stages or has metastasized (stage 4). It is used for patients with epidermal growth factor receptor (EGFR) T790M mutations: it can be used as first-line treatment for patients whose tumors have EGFR exon 19 deletion or exon 21 L858R mutation; it can also be used as second-line treatment for patients whose disease has progressed during or after EGFR·TKI treatment.

Osimertinib is a targeted therapy that helps slow or stop cancer cell growth or helps shrink tumors. It may help prevent lung cancer from returning after surgical removal, but it does not kill cancer cells. Targeted therapy is different from traditional chemotherapy. Chemotherapy kills rapidly dividing cells and affects many types of cells in the body, including healthy cells. Targeted treatments are designed for specific types of cancer and are designed to stop cancer cells from growing and spreading. Targeted therapy is not chemotherapy or immunotherapy. Osimertinib is a once-daily tablet that can be taken with or without food.

OsimertinibThe original drug has been launched in China and has been covered by medical insurance. The price of 80mg*30 tablets per box may be around 5,000 yuan, which is relatively expensive. Currently available overseas Osimertinib generics, such as the specifications produced by Bangladesh Pharmaceutical FactoryThe price of each box of 80mg*30 tablets may be more than 800 yuan (the price may fluctuate due to exchange rate effects), which is relatively cheap. Osimertinib generics have basically the same pharmaceutical ingredients as the original drugs sold domestically and abroad. For more drug information and specific prices, please consult Yaode Medical Consultant.